Lung cancer : new understandings and therapies / Anne C. Chiang, Roy S. Herbst, editors.

Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key strate...

Full description

Saved in:
Bibliographic Details
Other Authors: Chiang, Anne C. (Editor), Herbst, Roy (Editor)
Format: eBook
Language:English
Published: Cham, Switzerland : Springer, 2021.
Series:Current cancer research,
Subjects:
Online Access:Click for online access
Table of Contents:
  • Tumor Microenvironment: Immune Effector and Suppressor Imbalance
  • Biomarkers: is tumor mutational burden the new prognostic grail?
  • Liquid biopsies: new technology and evidence
  • Osimertinib in EGFR-Mutant Non-Small Cell Lung Carcinoma: Clinical Activity and Mechanisms of Resistance
  • What can we learn from acquired resistance?
  • Management of Brain Metastases
  • Spectrum and Management of Immune Related Adverse Events Due to Immune Checkpoint Inhibitors
  • Therapeutic Advances in Small Cell Lung Cancer Management
  • Small Cell Lung Cancer: Biology Advances
  • Immunotherapy and Radiotherapy: New Strategies
  • Ultimate Precision: Targeting Cancer but not Normal Self-Replication
  • Index.